Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11346867rdf:typepubmed:Citationlld:pubmed
pubmed-article:11346867lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:11346867lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:11346867lifeskim:mentionsumls-concept:C0543467lld:lifeskim
pubmed-article:11346867lifeskim:mentionsumls-concept:C0279563lld:lifeskim
pubmed-article:11346867lifeskim:mentionsumls-concept:C0678222lld:lifeskim
pubmed-article:11346867lifeskim:mentionsumls-concept:C0851346lld:lifeskim
pubmed-article:11346867lifeskim:mentionsumls-concept:C0034897lld:lifeskim
pubmed-article:11346867lifeskim:mentionsumls-concept:C0441766lld:lifeskim
pubmed-article:11346867lifeskim:mentionsumls-concept:C0334381lld:lifeskim
pubmed-article:11346867lifeskim:mentionsumls-concept:C0205276lld:lifeskim
pubmed-article:11346867lifeskim:mentionsumls-concept:C0442805lld:lifeskim
pubmed-article:11346867lifeskim:mentionsumls-concept:C1707391lld:lifeskim
pubmed-article:11346867lifeskim:mentionsumls-concept:C0332293lld:lifeskim
pubmed-article:11346867pubmed:issue10lld:pubmed
pubmed-article:11346867pubmed:dateCreated2001-5-10lld:pubmed
pubmed-article:11346867pubmed:abstractTextLobular carcinoma in situ (LCIS) is a known risk factor for the development of invasive breast carcinoma. However, little is known regarding the impact of LCIS in association with an invasive carcinoma on the risk of an ipsilateral breast tumor recurrence (IBTR) in patients who are treated with conservative surgery (CS) and radiation therapy (RT). The purpose of this study was to examine the influence of LCIS on the local recurrence rate in patients with early stage breast carcinoma after breast-conserving therapy.lld:pubmed
pubmed-article:11346867pubmed:languageenglld:pubmed
pubmed-article:11346867pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11346867pubmed:citationSubsetAIMlld:pubmed
pubmed-article:11346867pubmed:statusMEDLINElld:pubmed
pubmed-article:11346867pubmed:monthMaylld:pubmed
pubmed-article:11346867pubmed:issn0008-543Xlld:pubmed
pubmed-article:11346867pubmed:authorpubmed-author:PatchefskyAAlld:pubmed
pubmed-article:11346867pubmed:authorpubmed-author:HoffmanJ PJPlld:pubmed
pubmed-article:11346867pubmed:authorpubmed-author:EisenbergB...lld:pubmed
pubmed-article:11346867pubmed:authorpubmed-author:TorosianM HMHlld:pubmed
pubmed-article:11346867pubmed:authorpubmed-author:FowbleBBlld:pubmed
pubmed-article:11346867pubmed:authorpubmed-author:SigurdsonE...lld:pubmed
pubmed-article:11346867pubmed:authorpubmed-author:BoraasMMlld:pubmed
pubmed-article:11346867pubmed:authorpubmed-author:FreedmanGGlld:pubmed
pubmed-article:11346867pubmed:authorpubmed-author:HanlonA LALlld:pubmed
pubmed-article:11346867pubmed:authorpubmed-author:SassonA RARlld:pubmed
pubmed-article:11346867pubmed:copyrightInfoCopyright 2001 American Cancer Society.lld:pubmed
pubmed-article:11346867pubmed:issnTypePrintlld:pubmed
pubmed-article:11346867pubmed:day15lld:pubmed
pubmed-article:11346867pubmed:volume91lld:pubmed
pubmed-article:11346867pubmed:ownerNLMlld:pubmed
pubmed-article:11346867pubmed:authorsCompleteYlld:pubmed
pubmed-article:11346867pubmed:pagination1862-9lld:pubmed
pubmed-article:11346867pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:11346867pubmed:meshHeadingpubmed-meshheading:11346867...lld:pubmed
pubmed-article:11346867pubmed:meshHeadingpubmed-meshheading:11346867...lld:pubmed
pubmed-article:11346867pubmed:meshHeadingpubmed-meshheading:11346867...lld:pubmed
pubmed-article:11346867pubmed:meshHeadingpubmed-meshheading:11346867...lld:pubmed
pubmed-article:11346867pubmed:meshHeadingpubmed-meshheading:11346867...lld:pubmed
pubmed-article:11346867pubmed:meshHeadingpubmed-meshheading:11346867...lld:pubmed
pubmed-article:11346867pubmed:meshHeadingpubmed-meshheading:11346867...lld:pubmed
pubmed-article:11346867pubmed:meshHeadingpubmed-meshheading:11346867...lld:pubmed
pubmed-article:11346867pubmed:meshHeadingpubmed-meshheading:11346867...lld:pubmed
pubmed-article:11346867pubmed:meshHeadingpubmed-meshheading:11346867...lld:pubmed
pubmed-article:11346867pubmed:meshHeadingpubmed-meshheading:11346867...lld:pubmed
pubmed-article:11346867pubmed:meshHeadingpubmed-meshheading:11346867...lld:pubmed
pubmed-article:11346867pubmed:meshHeadingpubmed-meshheading:11346867...lld:pubmed
pubmed-article:11346867pubmed:meshHeadingpubmed-meshheading:11346867...lld:pubmed
pubmed-article:11346867pubmed:meshHeadingpubmed-meshheading:11346867...lld:pubmed
pubmed-article:11346867pubmed:meshHeadingpubmed-meshheading:11346867...lld:pubmed
pubmed-article:11346867pubmed:year2001lld:pubmed
pubmed-article:11346867pubmed:articleTitleLobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation.lld:pubmed
pubmed-article:11346867pubmed:affiliationDepartment of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19104, USA.lld:pubmed
pubmed-article:11346867pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11346867lld:pubmed